FDA Adverse Event Malfunction Summary report: N

COBAS E 601 MODULE

MDR report key: 17309093 · Received July 12, 2023

Report

Report Number
1823260-2023-02227
Event Type
Malfunction
Date Received
July 12, 2023
Date of Event
June 16, 2023
Report Date
July 21, 2023
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
UDI-DI
04015630924714
PMA / PMN Number
K060373
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MX
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AFTER INVESTIGATIONS PERFORMED AT THE CUSTOMER SITE, IT WAS DETERMINED THAT THE CUSTOMER'S WATER FILTERING DEVICE DID NOT HAVE ENOUGH CAPACITY TO SUPPLY A SUFFICIENT AMOUNT OF WATER WITH THE DEDICATED PRESSURE TO THE ANALYZER. THE WATER FILTERING DEVICE WAS REPLACED BY A LARGER ONE. THE LABORATORY IS AT A HIGH ALTITUDE (> 2100 M.) AND THE INSTRUMENT IS SPECIFIED FOR USE BELOW 2000 M. THE INVESTIGATION DETERMINED THE DEVICE WAS OPERATING IN THE LABORATORY OUTSIDE OF SPECIFICATIONS.

Additional Manufacturer Narrative · 0

THE SERIAL NUMBER OF THE COBAS 6000 E601 MODULE IS (B)(6).

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH ELECSYS HCG+BETA ON A COBAS 6000 E601 MODULE. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE INITIALLY RESULTED IN AN HCG+B VALUE OF 1.16 MIU/ML ACCOMPANIED BY A DATA FLAG INDICATING CARRYOVER. THE SAMPLE WAS RE-PROCESSED WITH A 1:50 DILUTION AND THIS REPEAT JCG+B VALUE WAS 33.39 MIU/ML. THE SAMPLE WAS THEN REPEATED ON A SECOND ANALYZER, RESULTING IN A VALUE 1.51 MIU/ML. THIS VALUE WAS CONSIDERED CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1616919 COBAS E 601 MODULE IMMUNOCHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS E601 64377007 04015630924714
748370 COBAS E 601 MODULE IMMUNOCHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS E601 64377007 04015630924714

Patients

Seq Age Sex Outcome Treatment
1 Female